Last $10.87 USD
Change Today -0.48 / -4.23%
Volume 572.1K
IMGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:16 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel M. Junius

Chief Executive Officer, President and Director, ImmunoGen, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 3 different organizations across 4 different industries.

See Board Relationships
62$2,384,585
As of Fiscal Year 2013

Background*

Mr. Daniel M. Junius, also known as Dan, has been the Chief Executive Officer and President of ImmunoGen, Inc. since July 29, 2008 and January 1, 2009 respectively. Mr. Junius served as an Acting Chief Financial Officer of ImmunoGen, Inc. from September 13, 2013 to December 30, 2013. He joined ImmunoGen in May 2005 and served as its Acting Chief Financial Officer from July 2008 to January 2009, Executive Vice President from July 2006 to July 2008, Treasurer until July ...

Read Full Background

Corporate Headquarters*

830 Winter Street
Waltham, Massachusetts 02451

United States

Phone: 781-895-0600
Fax: 781-895-0611

Board Members Memberships*

1996-Present
Director
2008-Present
Chief Executive Officer, President and Director
2014-Present
Director and Member of Audit Committee

Education*

BA
Boston College
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

Salary$495,000
Total Annual Compensation$495,000

Stock Options*

All Other Compensation$8,445
Exercisable Options938,664
Exercisable Options Value$9,084,734
Unexercisable Options360,000
Unexercisable Options Value$750,600
Total Value of Options$9,835,334
Total Number of Options1,298,664

Total Compensation*

Total Annual Cash Compensation$775,695
Total Short Term Compensation$495,000
Other Long Term Compensation$8,445
Total Calculated Compensation$2,384,585
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMGN:US $10.87 USD -0.48

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€772.6K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr10.7M
Edwin Moses Ph.D.Chief Executive Officer and Director
Ablynx NV
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.